Biosimulation Market Size, Share & Trends Report

Biosimulation Market Size, Share & Trends Analysis Report By Product (Software, Services), By Application (Drug Development, Drug Discovery), By End Use, By Region, And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-1-68038-051-4
  • Number of Pages: 170
  • Format: Electronic (PDF)
  • Historical Range: 2017 - 2020
  • Industry: Healthcare

Table of Contents

Chapter 1 Methodology and Scope
                   1.1 Market Segmentation and Scope
                       1.1.1 segment scope
                       1.1.2 regional scope
                       1.1.3 Estimates and forecast timeline
                   1.2 Research Methodology
                   1.3 Information procurement
                       1.3.1 Purchased database:
                       1.3.2 GVR’s internal database
                       1.3.3 Secondary sources
                       1.3.4 Primary research
                       1.3.5 Details of primary research
                   1.4 Information or Data Analysis
                       1.4.1 Data analysis models
                   1.5 Market Formulation & Validation
                   1.6 Model Details
                   1.7 List of Secondary Sources
                   1.8 Objectives
                       1.8.1 Objective 1
                       1.8.2 Objective 2
                       1.8.3 Objective 3
                       1.8.4 Objective 4
Chapter 2 Executive Summary
                   2.1 Biosimulation Market Summary
Chapter 3 Biosimulation Market Variables, Trends & Scope
                   3.1 Biosimulation Market Segmentation and Scope
                   3.2 Biosimulation Market Dynamics
                       3.2.1 Market driver analysis
                       3.2.2 Impact analysis
                           3.2.2.1 Increasing adoption of Physiologically Based Pharmacokinetic Modeling in the regulatory approval process of drugs
                           3.2.2.2 Growing number of relapse cases due to increasing drug resistance
                           3.2.2.3 Rising Technological advancements
                           3.2.2.4 Increasing need to reduce drug discovery and development costs
                           3.2.2.5 accelerating formulation development and saving costly studies
                           3.2.2.6 Increasing investments in the life sciences industry
                           3.2.2.7 Increasing use of personalized medicine
                       3.2.3 Market restraint analysis
                       3.2.4 Impact analysis
                           3.2.4.1 Lack of standardization
                           3.2.4.2 Shortage of skilled professionals
                           3.2.4.3 Intellectual property protection and public policy issues
                   3.3 Penetration and Growth Prospect Mapping, 2021
                   3.4 Pricing Analysis
                   3.5 Biosimulation Market Analysis Tools: Porters
                       3.5.1 Bargaining power of Suppliers: Low
                       3.5.2 Bargaining power of Buyers: Moderate
                       3.5.3 Threat of Substitutes: Low
                       3.5.4 Threat of New Entrants: High
                       3.5.5 Competitive Rivalry: High
                   3.6 SWOT Analysis by Factors (Political & Legal, Economic, and Technological)
                       3.6.1 Political/Legal Landscape
                       3.6.2 Economic Landscape
                       3.6.3 Technology Landscape
Chapter 4 Biosimulation Market: Impact of COVID-19
                   4.1 Impact of Covid-19 on the Biosimulation Market
                       4.1.1 Current And Future Impact Analysis
                       4.1.2 Impact of covid-19 on market players
                       4.1.3 Disease Prevalence Analysis
Chapter 5 Biosimulation Market: Segment Analysis, By Product, 2017 - 2030 (USD Million)
                   5.1 Definition and Scope
                   5.2 Product Market Share Analysis, 2021 & 2030
                   5.3 Biosimulation Market, by Product, 2017 - 2030
                   5.4 Software
                       5.4.1 software market, 2017 - 2030 (USD Million)
                   5.5 Services
                       5.5.1 Services market, 2017 - 2030 (USD Million)
                       5.5.2 In-house Services
                           5.5.2.1 In-house Services market, 2017 - 2030 (USD Million)
                       5.5.3 Contract Services
                           5.5.3.1 Contract Services market, 2017 - 2030 (USD Million)
Chapter 6 Biosimulation Market: Segment Analysis, By Application, 2017 - 2030 (USD Million)
                   6.1 Definition and Scope
                   6.2 Application Market Share Analysis, 2021 & 2030
                   6.3 Biosimulation Market, by Application, 2017 - 2030
                   6.4 Drug Development
                       6.4.1 Drug development market, 2017 - 2030 (USD Million)
                   6.5 Drug Discovery
                       6.5.1 Drug Discovery market, 2017 - 2030 (USD Million)
                   6.6 Others
                       6.6.1 Others market, 2017 - 2030 (USD Million)
Chapter 7 Biosimulation Market: Segment Analysis, By Delivery Model, 2017 - 2030 (USD Million)
                   7.1 Definition and Scope
                   7.2 Application Market Share Analysis, 2021 & 2030
                   7.3 Biosimulation Market, by Delivery Model, 2017 - 2030
                   7.4 Subscription Models
                       7.4.1 Subscription Models market, 2017 - 2030 (USD Million)
                   7.5 Ownership Models
                       7.5.1 Ownership Models market, 2017 - 2030 (USD Million)
Chapter 8 Biosimulation Market: Segment Analysis, By End-use, 2017 - 2030 (USD Million)
                   8.1 Definition and Scope
                   8.2 End-use Market Share Analysis, 2021 & 2030
                   8.3 Global Biosimulation Market, by End-use, 2017 - 2030
                   8.4 Pharmaceutical & Biotechnology Companies
                       8.4.1 Pharmaceutical & biotechnology companies market, 2017 - 2030 (USD Million)
                   8.5 CROs
                       8.5.1 CROs market, 2017 - 2030 (USD million)
                   8.6 Regulatory Authorities
                       8.6.1 Regulatory authorities market, 2017 - 2030 (USD Million)
                   8.7 Academic Research Institutions
                       8.7.1 Academic research institutions market, 2017 - 2030 (USD million)
Chapter 9 Biosimulation Market: Regional Market Analysis 2017 - 2030 (USD Million)
                   9.1 Definition & Scope
                   9.2 Regional Market Share Analysis, 2021 & 2030
                   9.3 Regional Market Snapshot
                   9.4 Market Size, & Forecasts, and Trend Analysis, 2017 - 2030
                   9.5 North America
                       9.5.1 North America Biosimulation Market Share Analysis, By Country, 2021
                       9.5.2 U.S.
                           9.5.2.1 U.S. Biosimulation Market, 2017 - 2030 (USD Million)
                       9.5.3 Canada
                           9.5.3.1 Canada Biosimulation Market, 2017 - 2030 (USD Million)
                   9.6 Europe
                       9.6.1 Europe Biosimulation Market Share Analysis, By Country, 2021
                       9.6.2 U.K.
                           9.6.2.1 U.K. Biosimulation Market, 2017 - 2030 (USD Million)
                       9.6.3 Germany
                           9.6.3.1 Germany Biosimulation Market, 2017 - 2030 (USD Million)
                       9.6.4 France
                           9.6.4.1 France Biosimulation Market, 2017 - 2030 (USD Million)
                   9.7 Asia Pacific
                       9.7.1 Asia Pacific Biosimulation Market Share Analysis, By Country, 2021
                       9.7.2 Japan
                           9.7.2.1 Japan Biosimulation Market, 2017 - 2030 (USD Million)
                       9.7.3 China
                           9.7.3.1 China Biosimulation Market, 2017 - 2030 (USD million)
                       9.7.4 India
                           9.7.4.1 India Biosimulation Market, 2017 - 2030 (USD Million)
                   9.8 Latin America
                       9.8.1 Latin America Biosimulation Market Share Analysis, By Country, 2021
                       9.8.2 Brazil
                           9.8.2.1 Brazil Biosimulation Market, 2017 - 2030 (USD Million)
                       9.8.3 Mexico
                           9.8.3.1 Mexico Biosimulation Market, 2017 - 2030 (USD Million)
                   9.9 MEA
                       9.9.1 MEA Biosimulation Market Share Analysis, By Country, 2021
                       9.9.2 South Africa
                           9.9.2.1 South Africa Biosimulation Market, 2017 - 2030 (USD Million)
Chapter 10 Biosimulation Market - Competitive Analysis
                   10.1 Strategy Framework
                   10.2 Market Participant Categorization
                   10.3 Public Companies
                       10.3.1 Company market position analysis
                       10.3.2 Comparative analysis by product category
                   10.4 Private Companies
                       10.4.1 List of Private companies
                       10.4.2 List of Emerging companies in the Asia Pacific Region
Chapter 11 Biosimulation Market - Company Profiles
                   11.1 Certara, USA
                       11.1.1 Company overview
                       11.1.2 Financial performance
                       11.1.3 Product benchmarking
                       11.1.4 Strategic initiatives
                   11.2 Simulations Plus
                       11.2.1 Company overview
                       11.2.2 Financial performance
                       11.2.3 Product benchmarking
                       11.2.4 Strategic initiatives
                   11.3 Dassault Systèmes
                       11.3.1 Company overview
                       11.3.2 Financial performance
                       11.3.3 Product benchmarking
                       11.3.4 Strategic initiatives
                   11.4 Schrödinger, Inc.
                       11.4.1 Company overview
                       11.4.2 Financial performance
                       11.4.3 Product benchmarking
                       11.4.4 Strategic initiatives
                   11.5 Advanced Chemistry Development
                       11.5.1 Company overview
                       11.5.2 Product benchmarking
                       11.5.3 Strategic initiatives
                   11.6 Chemical Computing Group ULC
                       11.6.1 Company overview
                       11.6.2 Financial performance
                       11.6.3 Product benchmarking
                       11.6.4 Strategic initiatives
                   11.7 Physiomics Plc
                       11.7.1 Company overview
                       11.7.2 Financial performance
                       11.7.3 Product benchmarking
                       11.7.4 Strategic initiatives
                   11.8 Rosa & Co. LLC
                       11.8.1 Company overview
                       11.8.2 Product benchmarking
                       11.8.3 Strategic initiatives
                   11.9 Biosimulation Consulting Inc.
                       11.9.1 Company overview
                       11.9.2 Financial performance
                       11.9.3 Service benchmarking
                   11.10 Genedata AG
                       11.10.1 Company overview
                       11.10.2 Financial performance
                       11.10.3 Product benchmarking
                       11.10.4 Strategic initiatives
                   11.11 Instem Group of Companies
                       11.11.1 Company overview
                       11.11.2 Financial performance
                       11.11.3 Product benchmarking
                       11.11.4 Strategic initiatives
                   11.12 PPD, Inc.
                       11.12.1 Company overview
                       11.12.2 Financial performance
                       11.12.3 Service benchmarking
                       11.12.4 Strategic initiatives
                   11.13 Yokogawa Insilico Biotechnology GmbH
                       11.13.1 Company overview
                       11.13.2 Product benchmarking
                       11.13.3 Strategic initiatives
                   11.14 Immunetrics
                       11.14.1 Company overview
                       11.14.2 Product benchmarking
Chapter 12 KOL Commentary


List of Tables

Table. 1 List of secondary sources
Table. 2 List of products for major companies
Table. 3 List of private companies
Table. 4 List of emerging companies
Table. 5 North America biosimulation market, by country, 2017 - 2030 (USD Million)
Table. 6 North America biosimulation market, by product, 2017 - 2030 (USD Million)
Table. 7 North America biosimulation services market, by type, 2017 - 2030 (USD Million)
Table. 8 North America biosimulation market, by application, 2017 - 2030 (USD Million)
Table. 9 North America biosimulation market, by delivery model, 2017 - 2030 (USD Million)
Table. 10 North America biosimulation market, by end-use, 2017 - 2030 (USD Million)
Table. 11 U.S. biosimulation market, by product, 2017 - 2030 (USD Million)
Table. 12 U.S. biosimulation services market, by type, 2017 - 2030 (USD Million)
Table. 13 U.S. biosimulation market, by application, 2017 - 2030 (USD Million)
Table. 14 U.S. biosimulation market, by delivery model, 2017 - 2030 (USD Million)
Table. 15 U.S. biosimulation market, by end-use, 2017 - 2030 (USD Million)
Table. 16 Canada biosimulation market, by product, 2017 - 2030 (USD Million)
Table. 17 Canada biosimulation services market, by type, 2017 - 2030 (USD Million)
Table. 18 Canada biosimulation market, by application, 2017 - 2030 (USD Million)
Table. 19 Canada biosimulation market, by delivery model, 2017 - 2030 (USD Million)
Table. 20 Canada biosimulation market, by end-use, 2017 - 2030 (USD Million)
Table. 21 Europe biosimulation market, by country, 2017 - 2030 (USD Million
Table. 22 Europe biosimulation market, by product, 2017 - 2030 (USD Million)
Table. 23 Europe biosimulation services market, by type, 2017 - 2030 (USD Million)
Table. 24 Europe biosimulation market, by application, 2017 - 2030 (USD Million)
Table. 25 Europe biosimulation market, by delivery model, 2017 - 2030 (USD Million)
Table. 26 Europe biosimulation market, by end-use, 2017 - 2030 (USD Million)
Table. 27 Germany biosimulation market, by product, 2017 - 2030 (USD Million)
Table. 28 Germany biosimulation services market, by type, 2017 - 2030 (USD Million)
Table. 29 Germany biosimulation market, by application, 2017 - 2030 (USD Million)
Table. 30 Germany biosimulation market, by delivery model, 2017 - 2030 (USD Million)
Table. 31 Germany biosimulation market, by end-use, 2017 - 2030 (USD Million)
Table. 32 U.K. biosimulation market, by product, 2017 - 2030 (USD Million)
Table. 33 U.K. biosimulation services market, by type, 2017 - 2030 (USD Million)
Table. 34 U.K. biosimulation market, by application, 2017 - 2030 (USD Million)
Table. 35 U.K. biosimulation market, by delivery model, 2017 - 2030 (USD Million)
Table. 36 U.K. biosimulation market, by end-use, 2017 - 2030 (USD Million)
Table. 37 France biosimulation market, by product, 2017 - 2030 (USD Million)
Table. 38 France biosimulation services market, by type, 2017 - 2030 (USD Million)
Table. 39 France biosimulation market, by application, 2017 - 2030 (USD Million)
Table. 40 France biosimulation market, by delivery model, 2017 - 2030 (USD Million)
Table. 41 France biosimulation market, by end-use, 2017 - 2030 (USD Million)
Table. 42 Asia Pacific biosimulation market, by country, 2017 - 2030 (USD Million)
Table. 43 Asia Pacific biosimulation market, by product, 2017 - 2030 (USD Million)
Table. 44 Asia Pacific biosimulation services market, by type, 2017 - 2030 (USD Million)
Table. 45 Asia Pacific biosimulation market, by application, 2017 - 2030 (USD Million)
Table. 46 Asia Pacific biosimulation market, by delivery model, 2017 - 2030 (USD Million)
Table. 47 Asia Pacific biosimulation market, by end-use, 2017 - 2030 (USD Million)
Table. 48 Japan biosimulation market, by product, 2017 - 2030 (USD Million)
Table. 49 Japan biosimulation services market, by type, 2017 - 2030 (USD Million)
Table. 50 Japan biosimulation market, by application, 2017 - 2030 (USD Million)
Table. 51 Japan biosimulation market, by delivery model, 2017 - 2030 (USD Million)
Table. 52 Japan biosimulation market, by end-use, 2017 - 2030 (USD Million)
Table. 53 China biosimulation market, by product, 2017 - 2030 (USD Million)
Table. 54 China biosimulation services market, by type, 2017 - 2030 (USD Million)
Table. 55 China biosimulation market, by application, 2017 - 2030 (USD Million)
Table. 56 China biosimulation market, by delivery model, 2017 - 2030 (USD Million)
Table. 57 China biosimulation market, by end-use, 2017 - 2030 (USD Million)
Table. 58 India biosimulation market, by product, 2017 - 2030 (USD Million)
Table. 59 India biosimulation services market, by type, 2017 - 2030 (USD Million)
Table. 60 India biosimulation market, by application, 2017 - 2030 (USD Million)
Table. 61 India biosimulation market, by delivery model, 2017 - 2030 (USD Million)
Table. 62 India biosimulation market, by end-use, 2017 - 2030 (USD Million)
Table. 63 Latin America biosimulation market, by country, 2017 - 2030 (USD Million)
Table. 64 Latin America biosimulation market, by product, 2017 - 2030 (USD Million)
Table. 65 Latin America biosimulation services market, by type, 2017 - 2030 (USD Million)
Table. 66 Latin America biosimulation market, by application, 2017 - 2030 (USD Million)
Table. 67 Latin America biosimulation market, by delivery model, 2017 - 2030 (USD Million)
Table. 68 Latin America biosimulation market, by end-use, 2017 - 2030 (USD Million)
Table. 69 Brazil biosimulation market, by product, 2017 - 2030 (USD Million)
Table. 70 Brazil biosimulation services market, by type, 2017 - 2030 (USD Million)
Table. 71 Brazil biosimulation market, by application, 2017 - 2030 (USD Million)
Table. 72 Brazil biosimulation market, by delivery model, 2017 - 2030 (USD Million)
Table. 73 Brazil biosimulation market, by end-use, 2017 - 2030 (USD Million)
Table. 74 Mexico biosimulation market, by product, 2017 - 2030 (USD Million)
Table. 75 Mexico biosimulation services market, by type, 2017 - 2030 (USD Million)
Table. 76 Mexico biosimulation market, by application, 2017 - 2030 (USD Million)
Table. 77 Mexico biosimulation market, by delivery model, 2017 - 2030 (USD Million)
Table. 78 Mexico biosimulation market, by end-use, 2017 - 2030 (USD Million)
Table. 79 MEA biosimulation market, by country, 2017 - 2030 (USD Million)
Table. 80 MEA biosimulation market, by product, 2017 - 2030 (USD Million)
Table. 81 MEA biosimulation services market, by type, 2017 - 2030 (USD Million)
Table. 82 MEA biosimulation market, by application, 2017 - 2030 (USD Million)
Table. 83 MEA biosimulation market, by delivery model, 2017 - 2030 (USD Million)
Table. 84 MEA biosimulation market, by end-use, 2017 - 2030 (USD Million)
Table. 85 South Africa biosimulation market, by product, 2017 - 2030 (USD Million)
Table. 86 South Africa biosimulation services market, by type, 2017 - 2030 (USD Million)
Table. 87 South Africa biosimulation market, by application, 2017 - 2030 (USD Million)
Table. 88 South Africa biosimulation market, by delivery model, 2017 - 2030 (USD Million)
Table. 89 South Africa biosimulation market, by end-use, 2017 - 2030 (USD Million)


List of Figures

Fig. 1 Biosimulation market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Commodity Flow Analysis
Fig. 9 Biosimulation Market outlook (2021, USD Million)
Fig. 10 Biosimulation market segmentation and scope
Fig. 11 Biosimulation market dynamics analysis
Fig. 12 Biosimulation market driver and restraints impact analysis
Fig. 13 Biosimulation market driver analysis
Fig. 14 Biosimulation market drivers impact analysis
Fig. 15 R&D expenditures by various market players in (USD Million)
Fig. 16 Biosimulation market restraint impact
Fig. 17 Biosimulation market restraint impact analysis
Fig. 18 Penetration & growth prospect mapping
Fig. 19 COVID- related events in major countries around the world
Fig. 20 Biosimulation market: Product movement analysis
Fig. 21 Biosimulation market product outlook: Key takeaways
Fig. 22 Software market, 2017 - 2030 (USD Million)
Fig. 23 Services market, 2017 - 2030 (USD Million)
Fig. 24 In-house Services market, 2017 - 2030 (USD Million)
Fig. 25 Contract Services market, 2017 - 2030 (USD Million)
Fig. 26 Biosimulation market: Application movement analysis
Fig. 27 Biosimulation market application outlook: Key takeaways
Fig. 28 Drug development market, 2017 - 2030 (USD Million)
Fig. 29 Drug discovery market, 2017 - 2030 (USD Million)
Fig. 30 Others market, 2017 - 2030 (USD Million)
Fig. 31 Biosimulation market: Delivery Model movement analysis
Fig. 32 Biosimulation market delivery model outlook: Key takeaways
Fig. 33 Subscription Models, 2017 - 2030 (USD Million)
Fig. 34 Ownership Models, 2017 - 2030 (USD Million)
Fig. 35 Biosimulation market: End-use movement analysis
Fig. 36 Biosimulation market end-use outlook: Key takeaways
Fig. 37 Pharmaceutical & biotechnology companies market, 2017 - 2030 (USD Million)
Fig. 38 CROs market, 2017 - 2030 (USD Million)
Fig. 39 Regulatory authorities market, 2017 - 2030 (USD Million)
Fig. 40 Academic research institutions market, 2017 - 2030 (USD Million)
Fig. 41 Regional outlook, 2021 & 2030
Fig. 42 Regional marketplace: Key takeaways
Fig. 43 North America Biosimulation market share, by country, 2021
Fig. 44 U.S. biosimulation market, 2017 - 2030 (USD Million)
Fig. 45 Canada biosimulation market, 2017 - 2030 (USD Million)
Fig. 46 Europe biosimulation market share analysis, by country, 2021
Fig. 47 U.K. Biosimulation market, 2017 - 2030 (USD Million)
Fig. 48 Germany biosimulation market, 2017 - 2030 (USD Million)
Fig. 49 France biosimulation market, 2017 - 2030 (USD Million)
Fig. 50 Asia Pacific biosimulation market share analysis, by country, 2021
Fig. 51 Japan biosimulation market, 2017 - 2030 (USD Million)
Fig. 52 China biosimulation market, 2017 - 2030 (USD Million)
Fig. 53 India biosimulation market, 2017 - 2030 (USD Million)
Fig. 54 Latin America Biosimulation market share analysis, by country, 2021
Fig. 55 Brazil biosimulation market, 2017 - 2030 (USD Million)
Fig. 56 Mexico Biosimulation market, 2017 - 2030 (USD Million)
Fig. 57 MEA biosimulation market share analysis, by country, 2021
Fig. 58 South Africa biosimulation market, 2017 - 2030 (USD Million)
Fig. 59 Strategy framework
Fig. 60 Market participant categorization
Fig. 61 Biosimulation: Heat Map Analysis
Fig. 62 Biosimulation market: Application-wise product ranking

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon gvr sidebar D&B icon gvr sidebar

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.